FGF23 and cardiac hypertrophy: Neither did the absence of Fgf23 in Fgf23−/−/VDRΔ/Δ animals protect against cardiac hypertrophy, nor did deletion of Klotho lead to further exacerbation of the TAC-induced hypertrophic phenotype, relative to VDRΔ/Δ controls.